Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03250325
What this trial is testing

Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma

Who this might be right for
Synovial Sarcoma
Takara Bio Inc. 8
Early research (Phase 1)Looking for participantsNCT05183490
What this trial is testing

R-MVST Cells for Treatment of Viral Infections

Who this might be right for
Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more
Columbia University 36
Not applicableActive Not RecruitingNCT04911478
What this trial is testing

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 50
Not applicableStudy completedNCT06391814
What this trial is testing

Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)

Who this might be right for
EBV Associated Lymphoma
Ciusss de L'Est de l'Île de Montréal 1
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Testing effectiveness (Phase 2)Looking for participantsNCT07551362
What this trial is testing

Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT01807182
What this trial is testing

Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+3 more
Fred Hutchinson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT03269526
What this trial is testing

BATs Treatment for Pancreatic Cancer, Phase Ib/II

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
University of Virginia 22
Early research (Phase 1)Active Not RecruitingNCT03330691
What this trial is testing

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

Who this might be right for
LeukemiaLymphoma
Seattle Children's Hospital 78
Testing effectiveness (Phase 2)Study completedNCT04426669
What this trial is testing

Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Who this might be right for
Gastrointestinal Epithelial CancerGastrointestinal NeoplasmsCancer of Gastrointestinal Tract+8 more
Intima Bioscience, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT02111850
What this trial is testing

T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive

Who this might be right for
Cervical CancerRenal CancerUrothelial Cancer+2 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Ended earlyNCT01585415
What this trial is testing

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Who this might be right for
Metastatic CancerMelanoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00566098
What this trial is testing

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Not applicableEnded earlyNCT00001064
What this trial is testing

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Ended earlyNCT02584829
What this trial is testing

Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Polyomavirus InfectionStage IV Merkel Cell Carcinoma AJCC v7
Fred Hutchinson Cancer Center 8
Early research (Phase 1)Looking for participantsNCT07078929
What this trial is testing

Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Relapse B Acute Lymphoblastic LeukemiaRefactory Childhood Acute Lymphoblastic Leukemia
Chulalongkorn University 16
Early research (Phase 1)Study completedNCT00438984
What this trial is testing

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11
Early research (Phase 1)Study completedNCT00301730
What this trial is testing

Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung

Who this might be right for
Breast CancerMetastatic Cancer
National Cancer Institute (NCI) 1
Not applicableUnknownNCT01691664
What this trial is testing

Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Capital Medical University 40
Early research (Phase 1)Study completedNCT02845999
What this trial is testing

Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab

Who this might be right for
Gastrointestinal Metastatic Cancer
Centre Hospitalier Universitaire de Besancon 9
Next Page